These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38243809)

  • 1. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study.
    Byrne JF; Healy C; Föcking M; Susai SR; Mongan D; Wynne K; Kodosaki E; Heurich M; de Haan L; Hickie IB; Smesny S; Thompson A; Markulev C; Young AR; Schäfer MR; Riecher-Rössler A; Mossaheb N; Berger G; Schlögelhofer M; Nordentoft M; Chen EYH; Verma S; Nieman DH; Woods SW; Cornblatt BA; Stone WS; Mathalon DH; Bearden CE; Cadenhead KS; Addington J; Walker EF; Cannon TD; Cannon M; McGorry P; Amminger P; Cagney G; Nelson B; Jeffries C; Perkins D; Cotter DR
    Schizophr Bull; 2024 Apr; 50(3):579-588. PubMed ID: 38243809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence.
    Mongan D; Föcking M; Healy C; Susai SR; Heurich M; Wynne K; Nelson B; McGorry PD; Amminger GP; Nordentoft M; Krebs MO; Riecher-Rössler A; Bressan RA; Barrantes-Vidal N; Borgwardt S; Ruhrmann S; Sachs G; Pantelis C; van der Gaag M; de Haan L; Valmaggia L; Pollak TA; Kempton MJ; Rutten BPF; Whelan R; Cannon M; Zammit S; Cagney G; Cotter DR; McGuire P;
    JAMA Psychiatry; 2021 Jan; 78(1):77-90. PubMed ID: 32857162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial.
    Susai SR; Mongan D; Healy C; Cannon M; Cagney G; Wynne K; Byrne JF; Markulev C; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Street R; Thompson A; Ruth Yung A; Nelson B; McGorry PD; Föcking M; Paul Amminger G; Cotter D
    Brain Behav Immun; 2022 Jul; 103():50-60. PubMed ID: 35341915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state.
    Kotlicka-Antczak M; Karbownik MS; Stawiski K; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Fusar-Poli P
    Eur Psychiatry; 2019 May; 58():72-79. PubMed ID: 30870626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
    Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW
    Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
    Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
    Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms.
    Healy C; Byrne J; Raj Suasi S; Föcking M; Mongan D; Kodosaki E; Heurich M; Cagney G; Wynne K; Bearden CE; Woods SW; Cornblatt B; Mathalon D; Stone W; Cannon TD; Addington J; Cadenhead KS; Perkins D; Jeffries C; Cotter D
    Brain Behav Immun; 2024 Mar; 117():175-180. PubMed ID: 38219978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.
    Addington J; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Santesteban-Echarri O; Woods SW
    Psychol Med; 2019 Jul; 49(10):1670-1677. PubMed ID: 30176955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone WS; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Schizophr Bull; 2022 Mar; 48(2):395-404. PubMed ID: 34581405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
    Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
    Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
    Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.
    Di Biase MA; Cetin-Karayumak S; Lyall AE; Zalesky A; Cho KIK; Zhang F; Kubicki M; Rathi Y; Lyons MG; Bouix S; Billah T; Anticevic A; Schleifer C; Adkinson BD; Ji JL; Tamayo Z; Addington J; Bearden CE; Cornblatt BA; Keshavan MS; Mathalon DH; McGlashan TH; Perkins DO; Cadenhead KS; Tsuang MT; Woods SW; Stone WS; Shenton ME; Cannon TD; Pasternak O
    Mol Psychiatry; 2021 Nov; 26(11):6833-6844. PubMed ID: 34024906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.